NCT05019508View on ClinicalTrials.gov

Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

August 18, 2022

Study Completion Date

April 10, 2023

Conditions
Gestational Diabetes
Trial Locations (1)

22903

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER

NCT05019508 - Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus | Biotech Hunter | Biotech Hunter